Start:
July 2009
End:
July 2017
Enrollment:
550
The purpose of this study is to determine the eligibility of individuals for Alzheimer's disease clinical trials.
Minimum Age: 45 Years
Maximum Age: N/A
++Age 45 or older++History of progressive memory impairment++Caregiver who is willing to accompany the subject to the National Institutes of Health Clinical Center
++Diagnosis of a non-Alzheimer's dementia, including frontotemporal dementia, normal pressure hydrocephalus, Lewy body dementia, Parkinson's disease dementia, Huntington's disease, or vascular dementia ++Pregnant women; women of childbearing potential will be screened by history for the possibility of pregnancy and undergo a urine pregnancy test ++Any medical contraindication to the procedures performed in the study or any current severe medical or psychiatric illness other than Alzheimer's++Behavioral symptoms that preclude the gathering of data for the study or advanced disease such that volunteers cannot provide assent
Contact study personnel listed either under the general study contact or the location nearest you.
Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.
Lead: National Institute of Mental Health (NIMH)
Source: ClinicalTrials.gov ID: NCT00955422
An official website of the U.S. government, managed by the National Institute on Aging at the National Institutes of Health